ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Most of NCI’s Increase For Breast Cancer to Fund Grants: Broder

May 21, 1993

In Brief: DCE Board Nixes NIH Intramural Postdoctural Program Magazines Rapped For Cigarette Ads

July 13, 1984

In Brief: Gusberg Heads ACS, With Scanlon As President Elect; MDA honors Holland, D’Angio, Landing

November 16, 1979

UICC Announces Four Grant award Programs

July 14, 1978

Duke Insiders Allege Intimidation By Administration

July 23, 2010

In Brief: BRI Gets New FCRF Basic Research Contract; Senate Subcommittee Less Generous Than House

October 2, 1987